<DOC>
	<DOCNO>NCT01218308</DOCNO>
	<brief_summary>This study design test efficacy investigational influenza vaccine , child compare HavrixÂ® , license Hepatitis A virus vaccine . This study also evaluate immunogenicity safety investigational vaccine .</brief_summary>
	<brief_title>A Study Evaluate Efficacy GSK Biologicals ' Influenza Vaccine Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe and/or parent ( ) legally acceptable representative ( ) comply requirement protocol . A male female child age 3 8 year inclusive time first vaccination ; child eligible regardless history administration influenza vaccine previous season . However , subject receive seasonal pandemic influenza vaccine within 6 month precede first dose study vaccine enrol . Written inform consent obtain subject/from parent ( ) /legally acceptable representative ( ) subject . Written assent obtain subject if/as require local regulation . Subjects stable health determine investigator 's clinical examination assessment subject ' medical history . Access consistent mean telephone contact Child care . Use investigational nonregistered product study vaccine within 30 day study vaccination plan use study period . Routine register childhood vaccination permit . Prior receipt seasonal pandemic influenza vaccine within 6 month precede first dose study vaccine , plan use vaccine study period . Prior receipt one dose license hepatitis A vaccine , first dose administered &gt; =12 month age . Chronic administration immunosuppressant immunemodifying drug within 6 month prior first vaccine dose . Administration immunoglobulins and/or blood product within 3 month precede first dose study vaccine plan administration study period . History GuillainBarre syndrome within 6 week receipt prior influenza virus vaccine . Any known suspected allergy constituent influenza vaccine ; history anaphylactictype reaction constituent vaccine ; history severe adverse reaction previous influenza vaccine . Fever time enrolment . Acute disease time enrolment . Any significant disorder coagulation treatment Coumadin derivatives heparin . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . Ongoing aspirin therapy . Any condition , opinion Investigator , prevents subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Influenza</keyword>
</DOC>